10x Genomics, Inc. TXG Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Spatial | $153.64M+6.7% | $143.98M+3.7% | $138.81M+4.3% | $133.11M+5.7% | $125.96M+4.0% | |
| Revenue by Geography | ||||||
| Americas (excluding United States) | $11.92M-2.8% | $12.26M+2.3% | $11.98M-3.8% | $12.45M-5.7% | $13.21M-1.8% | |
| Asia-Pacific (excluding China) | $54.59M+4.8% | $52.07M+4.0% | $50.06M+2.8% | $48.7M-0.1% | $48.76M+6.1% | |
| China | $69.22M-1.5% | $70.26M+0.6% | $69.85M+0.2% | $69.69M+15.7% | $60.26M+5.2% | |
| Europe, Middle East and Africa | $166.67M+3.1% | $161.72M+2.3% | $158.08M+2.4% | $154.31M-1.7% | $156.94M-1.8% | |
| United States | $336.39M-2.9% | $346.51M-1.5% | $351.84M-2.1% | $359.32M+4.0% | $345.5M+3.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does 10x Genomics, Inc. break its business down?
- 10x Genomics, Inc. (TXG) reports total revenue by product across 2 parts — Single Cell and Spatial. Each is extracted from the segment footnotes and tracked over time.
- Where does 10x Genomics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in 10x Genomics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.